Mahamaya Lifescience - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 -Utilisation Of Unutilised IPO Proceed

We wish to inform you that the Board of Directors of the Company, through a circular resolution passed today, has approved the utilisation of the unutilized IPO proceeds in subsequent fiscal years i.e. upto March 31, 2028 in phased manner.